TITLE

Late postoperative pleural effusion following lung transplantation: characteristics and clinical implications

AUTHOR(S)
Shitrit, David; Izbicki, Gabriel; Fink, Gershon; Bendayan, Daniel; Aravot, Dan; Saute, Milton; Kramer, Mordechai R.
PUB. DATE
April 2003
SOURCE
European Journal of Cardio-Thoracic Surgery;Apr2003, Vol. 23 Issue 4, p494
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: Pleural effusions are extremely common in the early postoperative period after lung transplantation (LTX). It occurs in all transplant recipients, and like pleural fluid following other cardiothoracic surgery is bloody, exudative and neutrophil predominant. There was no information, however, on the characteristics of the late (14–45 days) postoperative pleural fluid after LTX. The purpose of this study was to describe the characteristics and the clinical implications of late postoperative pleural effusion after LTX. Methods: Thirty-five patients underwent TX between May 1997 and May 2001. Seven patients (20%) developed late postoperative pleural effusion. Thoracentesis were performed in these patients and the white blood cell counts, cell differential as well as biochemical parameters were determined. Results: The median time for late pleural effusion appearance was 23 days (range, 14–34 days) after TX. The pleural effusions were medium in size (700 ml, range, 100–1300), exudative in all the patients and had lymphocyte predominance. No evidence of fluid recurrence or clinical deterioration was noted in these patients. Conclusion: Late-onset exudative lymphocytic pleural effusion after LTX is not uncommon. When there is no evidence of rejection or infection, it usually has a benign, favorable outcome.
ACCESSION #
9500048

 

Related Articles

  • Male rejection.  // New Scientist;11/4/95, Vol. 148 Issue 2002, p12 

    Reports that livers donated by men are more likely to be rejected than livers from female donors. Association between sex of donors and organ rejection in liver transplants.

  • Complement in transplant rejection: diagnostic and mechanistic considerations. Baldwin, William M.; Ota, Hirofumi; Rodriguez, E. Rene // Springer Seminars in Immunopathology;Sep2003, Vol. 25 Issue 2, p181 

    After decades of neglect, complement has been rediscovered as a potent mediator and diagnostic indicator of inflammation and rejection in organ transplants. In part, this reflects a better understanding of the biology of complement, but it also reflects changes in clinical practice. The...

  • Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Maier, Stefan; Tertilt, Christine; Chambron, Nicole; Gerauer, Klaus; Hüser, Norbert; Heidecke, Claus-Dieter; Pfeffer, Klaus // Nature Medicine;May2001, Vol. 7 Issue 5, p557 

    Successful transplantation of allogeneic organs is an important objective in modern medicine. However, sophisticated immune defense mechanisms, primarily evolved to combat infections, often work against medical transplantation. To investigate the roles of natural and adaptive immune responses in...

  • Severe Early Rejection Predicts Graft Outcome.  // Kidney;Jan/Feb98, Vol. 7 Issue 1, p32 

    Assesses the impact on graft survival of rejection episodes (RE) during the first year post renal transplantation. Long-term graft survival rates; Lack of effect of benign RE during the first year after transplant on long-term kidney graft outcome.

  • The impact of FTY720 (fingolimod) on vasodilatory function and arterial elasticity in renal transplant patients. Timm H. Westhoff; Sven Schmidt; Petra Glander; Lutz Liefeld; Sebastian Martini; Gerd Offermann; Hans H. Neumayer; Walter Zidek; Markus van der Giet; Klemens Budde // Nephrology Dialysis Transplantation;Aug2007, Vol. 22 Issue 8, p2354 

    Background. FTY720 has recently demonstrated a similar efficacy in prevention of acute graft rejection compared with mycophenolate mofetil (MMF) in a large phase III trial of de novo renal transplant recipients. Creatinine clearance, however, was significantly lower in FTY720-treated patients....

  • Xenotransplantation survival. Helwig, David // CMAJ: Canadian Medical Association Journal;10/17/2000, Vol. 163 Issue 8, p1032 

    Discusses the results of a study of the effect of the cytokines gamma interferon and interleukin-12 on xenotransplants in humans. Details of graft rejection rates among mice with high cytokine levels; How the findings contradict the belief that the cytokines have a negative influence on...

  • Chronic transplant rejection. Hostetter, Thomas H. // Kidney International;Jul1994, Vol. 46 Issue 1, p266 

    The article presents a case study of a patient with tubulointerstitial rejection and focal scarring with changes of chronic vascular rejection. A 30-year-old woman was admitted to the University of Minnesota Hospital to receive a second cadaveric renal transplant. Because of a rise in the serum...

  • Antibody-mediated rejection following transplantation from an HLA-identical sibling. Grafft, Carrie A.; Cornell, Lynn D.; Gloor, James M.; Cosio, Fernando G.; Gandhi, Manish J.; Dean, Patrick G.; Stegall, Mark D.; Amer, Hatem // Nephrology Dialysis Transplantation;Jan2010, Vol. 25 Issue 1, p307 

    Putative antibody-mediated rejection (AMR) in HLA-identical sibling transplantation has rarely been reported and occurred before routine calcineurin inhibitor use. A 29-year-old male developed allograft dysfunction following an HLA-identical renal transplant from his sibling. A pretransplant...

  • CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells. Hale, G; Jacobs, P; Wood, L; Fibbe, W E; Barge, R; Novitzky, N; Toit, C du; Abrahams, L; Thomas, V; Bunjes, D; Duncker, C; Wiesneth, M; Selleslag, D; Hidajat, M; Starobinski, M; Bird, P; Waldmann, H // Bone Marrow Transplantation;7/1/2000, Vol. 26 Issue 1, p69 

    Graft-versus-host disease (GVHD) is a major cause of mortality and morbidity after allogeneic bone marrow transplantation, but can be avoided by removing T lymphocytes from the donor bone marrow. However, T cell depletion increases the risk of graft rejection. In this study, two strategies are...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics